Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
52 results
- 3상모집 예정· Fibrodysplasia Ossificans Progressiva (FOP)FOP 아동 및 청소년 대상 가레토스마브의 안전성, 약물동력학 및 유효성 조사 연구
A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)
리드: 리제네론
- 3상모집 중· Venous Thromboembolism (VTE)고형 및 혈액 종양 성인 환자에서 정맥혈전색전증의 치료 및 이차 예방
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
리드: 리제네론
- 3상모집 예정· Multiple Myeloma이식 적격 신규 진단 다발성 골수종: Isa-Iber-VD 유도 후 적응형 공고화 및 유지치료
D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM
협력: BMS, 리제네론, 사노피
- 3상모집 예정· Venous Thromboembolism (VTE)말초 삽입 중심 정맥 카테터(PICC)를 가진 성인 및 청소년 참여자에서 REGN7508과 REGN9933을 이용한 정맥 혈전색전증(VTE) 예방
Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)
리드: 리제네론
- 3상모집 중· Atrial Fibrillation (AF)심방세동 성인 참가자에서 뇌졸중 및 전신 색전증 예방
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
리드: 리제네론
- 3상모집 중· Allergic Conjunctivitis고양이 알레르기로 인한 알레르기 결막염이 있는 성인 및 소아 참여자에서 Fel d 1 모노클로날 항체의 유효성 및 안전성을 평가하는 연구
A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy
리드: 리제네론
- 3상모집 중· Peripheral Artery Disease (PAD)말초 동맥 질환 환자에서 제11 인자 억제를 통한 혈관 합병증 감소
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
리드: 리제네론
- 3상모집 중· Paroxysmal Nocturnal Hemoglobinuria현재 치료에 반응하지 않는 발작성 야간 혈색소뇨증 환자에서 포젤리맙과 셈디시란 병용 치료의 효과 평가 연구
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
리드: 리제네론
- 3상모집 중· High Risk Smoldering Multiple Myeloma (HR-SMM)고위험 무증상 다발성 골수종에서 린보셀탐과 다라투무맙의 치료 효과 비교
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
리드: 리제네론
- 3상철회· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중· Atrial Fibrillation (AF)심방세동 환자의 뇌졸중 및 전신색전증 예방: 경구항응고제 부적절군 대상
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
리드: 리제네론
- 3상모집 중· Generalized LipodystrophyEfficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
리드: 리제네론
- 3상모집 중단 (진행 중)· Chronic Rhinosinusitis With Nasal PolypsAn Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중· Cancer-Associated Thrombosis (CAT)REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
리드: 리제네론
- 3상모집 중· Asthma ControlA Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
협력: 리제네론, 사노피
- 3상조기 종료· Allergic ConjunctivitisStudy of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
리드: 리제네론
- 3상모집 중· Relapsed and/or Refractory Multiple Myeloma (RRMM)A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
리드: 리제네론
- 3상모집 중· Symptomatic Venous Thromboembolism (VTE)REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
리드: 리제네론
- 3상모집 중· Eosinophilic Esophagitis (EoE)A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
리드: 리제네론 · 협력: 사노피
- 3상모집 중· Venous Thromboembolism (VTE)REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
리드: 리제네론
- 3상모집 중단 (진행 중)· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· Chronic Rhinosinusitis With Nasal PolypsA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
리드: 사노피 · 협력: 리제네론
- 3상모집 중· Cutaneous Squamous Cell Carcinoma (CSCC)Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
리드: 리제네론
- 3상모집 중· Age-related Macular Degeneration (AMD)A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
리드: 리제네론
- 3상모집 중단 (진행 중)· Neovascular Age-Related Macular DegenerationA Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
리드: 리제네론
- 3상모집 중· Prurigo NodularisA Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
리드: 사노피 · 협력: 리제네론
- 3상모집 중단 (진행 중)· B-Cell Non-Hodgkin Lymphoma (B-NHL)A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
리드: 리제네론
- 3상완료· Chronic Obstructive Pulmonary DiseaseA Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
리드: 사노피 · 협력: 리제네론
- 3상모집 중· Relapsed/Refractory Follicular LymphomaA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
리드: 리제네론
- 3상모집 중· Transthyretin Amyloidosis (ATTR) With CardiomyopathyMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
협력: 리제네론
- 3상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
- 3상모집 중· Paroxysmal Nocturnal HemoglobinuriaA Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
리드: 리제네론
- 3상모집 중단 (진행 중)· Fibrodysplasia Ossificans ProgressivaA Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
리드: 리제네론
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaA Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
리드: 리제네론
- 3상모집 중단 (진행 중)· Generalized Myasthenia GravisA Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
리드: 리제네론
- 3상모집 중단 (진행 중)· Cutaneous Squamous Cell CarcinomaStudy of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
리드: 리제네론
- 3상모집 중단 (진행 중)· Atopic DermatitisStudy to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
리드: 리제네론 · 협력: 사노피
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.